Jacqueline Skrutvold
Physician Assistant · Tucson, AZNPI 1306076435
Payments from drug & device makers
Across 151 payments — averaging $21.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$686
- AstraZeneca$550
- Merck$171
- Pfizer$153
- Daiichi Sankyo Inc.$137
- AbbVie$137
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,16895%
- Education$1505%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 39 | $686 |
| AstraZeneca | 18 | $550 |
| Merck | 9 | $171 |
| Pfizer | 7 | $153 |
| Daiichi Sankyo Inc. | 6 | $137 |
| AbbVie | 6 | $137 |
| Sobi, Inc | 4 | $136 |
| Ipsen Biopharmaceuticals, Inc | 6 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $117 |
| Sumitomo Pharma America, Inc. | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Genmab U.S., Inc. | 3 | $76 |
| Seagen Inc. | 1 | $75 |
| Johnson & Johnson | 4 | $71 |
| Blueprint Medicines Corporation | 3 | $68 |
| Bayer | 4 | $66 |
| Sanofi | 3 | $60 |
| Incyte Corporation | 3 | $57 |
| Lilly USA, LLC | 3 | $52 |
| Jazz Pharmaceuticals Inc. | 2 | $51 |
| GSK | 2 | $49 |
| Beigene USA, Inc. | 2 | $42 |
| Stemline Therapeutics Inc. | 2 | $36 |
| Exelixis Inc. | 2 | $34 |
| Mirati Therapeutics, Inc. | 2 | $33 |
| Geron Corporation | 1 | $26 |
| AVEO Pharmaceuticals, Inc. | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Adaptive Biotechnologies Corporation | 1 | $22 |
| Boehringer Ingelheim | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Dendreon Pharmaceuticals LLC | 1 | $14 |
How this compares
$3,318 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VerzenioAbemaciclib | 30 | $440,426 |
| IbrancePalbociclib | 18 | $285,278 |
| KisqaliRibociclib Succinate | 15 | $238,631 |
| EliquisApixaban | 17 | $24,030 |
| XareltoRivaroxaban | 15 | $21,222 |
| Letrozole | 203 | $5,536 |
| Tamoxifen Citrate | 139 | $3,562 |
| Duloxetine Hcl | 77 | $1,430 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $1,079 |
| Anastrozole | 43 | $846 |
| Gabapentin | 53 | $794 |
| ValacyclovirValacyclovir Hcl | 11 | $707 |
| Morphine Sulfate ErMorphine Sulfate | 16 | $411 |
| Rosuvastatin Calcium | 14 | $402 |
| Lisinopril | 52 | $376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCVerzenio | $52 | $440,42630 claims |
| PfizerIbrance, Eliquis | $153 | $309,30835 claims |
| NovartisKisqali | $686 | $238,63115 claims |
| Johnson & JohnsonXarelto | $71 | $21,22215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Tucson
- Nicole StokerTucson$61K
- Robert HoyTucson$41K
- Luis LozanoTucson$31K
- Christy HallTucson$30K
- Monica MettilleTucson$27K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.